STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $435,000 | -71.9% | 89,864 | -38.2% | 0.28% | -56.1% |
| Q4 2019 | $1,546,000 | +37.5% | 145,475 | +34.8% | 0.63% | +32.8% |
| Q3 2019 | $1,124,000 | -27.1% | 107,934 | +7.3% | 0.47% | -27.4% |
| Q2 2019 | $1,542,000 | -24.0% | 100,634 | -36.2% | 0.65% | -19.6% |
| Q1 2019 | $2,028,000 | +37.0% | 157,795 | +1.3% | 0.81% | +16.3% |
| Q4 2018 | $1,480,000 | -15.3% | 155,795 | +48.0% | 0.70% | +22.6% |
| Q3 2018 | $1,748,000 | +21.0% | 105,287 | +17.0% | 0.57% | +4.6% |
| Q2 2018 | $1,445,000 | +4.9% | 90,000 | 0.0% | 0.54% | -4.6% |
| Q1 2018 | $1,377,000 | +17.7% | 90,000 | +20.0% | 0.57% | +22.2% |
| Q4 2017 | $1,170,000 | +40.6% | 74,992 | 0.0% | 0.46% | +30.6% |
| Q3 2017 | $832,000 | +116.7% | 74,992 | +79.9% | 0.36% | +122.5% |
| Q2 2017 | $384,000 | +346.5% | 41,692 | +316.9% | 0.16% | +290.2% |
| Q1 2017 | $86,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |